Home » Topics » Regulatory

Regulatory
RSS

Japanese approval for new formulation of Fosrenol

Feb. 3, 2012

FDA approves ivacaftor for rare form of cystic fibrosis

Feb. 1, 2012

Jentadueto approved in U.S.

Jan. 31, 2012

FDA approves first treatment for advanced BCC

Jan. 31, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012

FDA expands Keppra indication

Jan. 26, 2012

FDA approves gel for actinic keratosis

Jan. 26, 2012

Extended indication for Rebif approved in E.U.

Jan. 25, 2012

FDA approves subcutaneous Velcade

Jan. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...